News

Published on 9 Dec 2022 on Zacks via Yahoo Finance

Allakos Inc. (ALLK) Moves to Buy: Rationale Behind the Upgrade


Article preview image

Allakos Inc. (ALLK) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.

Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.

NASDAQ.ALLK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

It was a low-key week for the biotech sector with no major updates. Regulatory and pipeline updat...

Zacks via Yahoo Finance 22 Jan 2024

Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug

Shares of Allakos ALLK plunged 60.2% on Tuesday after management announced disappointing results ...

Zacks via Yahoo Finance 14 Jan 2024

Is Allakos (ALLK) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 14 Jan 2024

Following a 63% decline over last year, recent gains may please Allakos Inc. (NASDAQ:ALLK)...

Key Insights Given the large stake in the stock by institutions, Allakos' stock price might be vu...

Simply Wall St. via Yahoo Finance 6 Nov 2023

Allakos Inc. (NASDAQ:ALLK) has caught the attention of institutional investors who hold a sizeable...

Key Insights Significantly high institutional ownership implies Allakos' stock price is sensitive...

Simply Wall St. via Yahoo Finance 13 May 2023

Novavax (NVAX) to Report Q1 Earnings: What's in the Cards?

We expect investors to focus on the pipeline when Novavax, Inc. NVAX reports first-quarter 2023 r...

Zacks via Yahoo Finance 25 Apr 2023

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In...

Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In...

Investing.com 7 Mar 2023

Is Allakos Inc. (NASDAQ:ALLK) Expensive For A Reason? A Look At Its Intrinsic Value

How far off is Allakos Inc. (NASDAQ:ALLK) from its intrinsic value? Using the most recent financi...

Simply Wall St. via Yahoo Finance 26 Jan 2023

Allakos Inc. (ALLK) Moves to Buy: Rationale Behind the Upgrade

Allakos Inc. (ALLK) could be a solid choice for investors given its recent upgrade to a Zacks Ran...

Zacks via Yahoo Finance 9 Dec 2022

After losing 95% in the past year, Allakos Inc. (NASDAQ:ALLK) institutional owners must be relieved...

A look at the shareholders of Allakos Inc. (NASDAQ:ALLK) can tell us which group is most powerful...

Simply Wall St. via Yahoo Finance 24 Sep 2022